Cardioprotective role of statins in chronic kidney disease: do we have the answer?
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 21490611.
- Also identified by DOI 10.1038/ki.2011.6.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The observational study by Szummer et al. shows that patients with advanced chronic kidney disease (CKD) are treated less with statins after myocardial infarction, even though statins benefit survival in CKD classes 1-4. The study's limitations are obvious, but such a population may be more representative. The results indicate that statins should be used more frequently after myocardial infarction in CKD classes lower than 5, a conclusion supported by the recently presented Study of Heart and Renal Protection (SHARP).
Medical subject headings
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Kidney Diseases
- Myocardial Infarction